Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays

Leukemia

Volumn 18, Issue 7, 2004, Pages 1270-1277

  Willenbrock, H ^a   Juncker, A S ^a   Schmiegelow, K ^b   Knudsen, Steen ^a   Ryder, L P ^c  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b Rigshospitalet   (Denmark)

^c Mental Health Services CPH   (Denmark)

Author keywords

Acute lymphoblastic leukemia; Classification; DNA microarray; Gene expression profiling; MRD prediction; Relapse prediction

Indexed keywords

DNA; DOXORUBICIN; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B CELL LEUKEMIA; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; MALE; MINIMAL RESIDUAL DISEASE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T CELL LEUKEMIA; TREATMENT OUTCOME; ACUTE LYMPHOCYTIC LEUKEMIA; CLUSTER ANALYSIS; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; INFANT; MORTALITY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; PROGNOSIS; RECURRENT DISEASE; STATISTICS;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; NEOPLASM, RESIDUAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 3142757248     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403392     Document Type: Article

References (20)

1. Hjalgrim LL, Rostgaard K, Schmiegelow K, Soderhall S, Kolmannskog S, Vettenranta K et al. Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries. J Natl Cancer Inst 2003; 95: 1539-1544.
2. Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 2000; 14: 2267-2275.
3. Pui CH, Relling MV, Campana D, Evans WE. Childhood acute lymphoblastic leukemia. Rev Clin Exp Hematol 2002; 6: 161-180, 200-202.
4. Ross ME, Zhou X, Song G, Shurtleff SA, Girtman K, Williams WK et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003; 102: 2951-2959.
5. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537.
6. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133-134.
7. Nyvold C, Madsen HO, Ryder LP, Seyfarth J, Svejgaard A, Clausen N, et al., Nordic Society for Pediatric Hematology and Oncology. Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome. Blood 2002; 99: 1253-1258.
8. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comp Graph Stat 1996; 5: 299-314.
9. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, Nielsen HB et al. A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol 2002; 3: 1-16.
10. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001; 98: 31-36.
11. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2001; 2: 1-11.
12. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
13. Knudsen S (ed). A Biologist's Guide to Analysis of DNA Microarray Data. New York: Wiley-Interscience, 2002.
14. Dudoit S, Fridlyand J. Introduction to classification in microarrray experiments. In: Berrar DP, Dubitzky W, Granzow M (eds). A Practical Approach to Microarray Data Analysis. Dordrecht: Kluwer Academic Publishers, 2003.
15. Dudoit S, Fridlyand J. Classification in microarray experiments. In: Speed T (ed). Statistical Analysis of Gene Expression Microarray Data, Interdisciplinary Statistics. Boca Raton, FL: CRC Press, 2003.
16. Dyrskjøt L, Thykjaer T, Kruhoffer M, Jensen JL, Marcussen N, Hamilton-Dutoit S et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 2003; 33: 90-96.
17. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002; 99: 6567-6572.
18. Conradsen K (ed). Diskriminantanalyse. In: En introduktion til statistik, Bind 2, 5th edn. Lyngby: IMM, 2002, pp 309-342.
19. Cortes C, Vapnik V. Support-vector network. Mach Learn 1995; 20: 1-25.
20. Matthews BW. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta 1975; 405: 442-451.